Annual report [Section 13 and 15(d), not S-K Item 405]

Income Taxes - Narrative (Details)

v3.25.4
Income Taxes - Narrative (Details) - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Income Tax Contingency [Line Items]      
Deferred tax assets, valuation allowance $ 11,327,659 $ 12,307,555  
Deferred tax assets, valuation allowance decrease 1,000,000.0    
Net operating loss carryforwards $ 10,200,000 $ 12,300,000  
Effective tax rate (16.80%) (0.30%)  
Accrued interest and penalties $ 178,000 $ 202,000  
Research Tax Credit Carryforward      
Income Tax Contingency [Line Items]      
Tax credits 14,000    
California Alternative Minimum Tax Credit      
Income Tax Contingency [Line Items]      
Tax credits 22,000    
Federal      
Income Tax Contingency [Line Items]      
Net operating loss carryforwards 2,100,000 2,600,000  
Net operating losses 7,800,000    
Net operating losses with an indefinite carryforward 2,300,000    
State and Local Jurisdiction      
Income Tax Contingency [Line Items]      
Net operating loss carryforwards 10,200,000 3,600,000  
Discontinued Operations, Held-for-Sale or Disposed of by Sale | Corporate Clinics      
Income Tax Contingency [Line Items]      
Deferred tax assets (attributable to VIEs) 994,138 1,087,204  
Uncertain tax positions 633,714 948,182 $ 1,175,766
Unrecognized tax benefits that if recognized would affect the annual effective tax rate $ 20,000 $ 22,000